Free Trial
NASDAQ:ELUT

Elutia (ELUT) Stock Price, News & Analysis

Elutia logo
$2.24 -0.17 (-6.88%)
As of 02:31 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Elutia Stock (NASDAQ:ELUT)

Key Stats

Today's Range
$2.27
$2.40
50-Day Range
$1.73
$2.46
52-Week Range
$1.61
$5.12
Volume
37,795 shs
Average Volume
35,723 shs
Market Capitalization
$94.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Buy

Company Overview

Elutia Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
74th Percentile Overall Score

ELUT MarketRank™: 

Elutia scored higher than 74% of companies evaluated by MarketBeat, and ranked 269th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Elutia has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Elutia has received no research coverage in the past 90 days.

  • Read more about Elutia's stock forecast and price target.
  • Earnings Growth

    Earnings for Elutia are expected to grow in the coming year, from ($1.74) to ($0.95) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Elutia is -2.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Elutia is -2.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Elutia's valuation and earnings.
  • Percentage of Shares Shorted

    0.09% of the float of Elutia has been sold short.
  • Short Interest Ratio / Days to Cover

    Elutia has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Elutia has recently decreased by 19.22%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Elutia does not currently pay a dividend.

  • Dividend Growth

    Elutia does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.09% of the float of Elutia has been sold short.
  • Short Interest Ratio / Days to Cover

    Elutia has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Elutia has recently decreased by 19.22%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Elutia has a news sentiment score of 1.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Elutia this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    1 people have added Elutia to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Elutia insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    27.60% of the stock of Elutia is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    74.03% of the stock of Elutia is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Elutia's insider trading history.
Receive ELUT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elutia and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ELUT Stock News Headlines

Elutia to Participate in Upcoming Investor Conferences
Elutia FY2025 EPS Forecast Boosted by Cantor Fitzgerald
This stock could leave NVDA in the dust
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.tc pixel
Elutia Inc. (ELUT) Q2 2025 Earnings Call Transcript
See More Headlines

ELUT Stock Analysis - Frequently Asked Questions

Elutia's stock was trading at $3.74 at the start of the year. Since then, ELUT stock has decreased by 39.0% and is now trading at $2.28.

Elutia Inc. (NASDAQ:ELUT) issued its quarterly earnings data on Thursday, August, 14th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.17) by $0.09. The business had revenue of $6.26 million for the quarter, compared to analyst estimates of $6.55 million.
Read the conference call transcript
.

Top institutional shareholders of Elutia include AIGH Capital Management LLC (8.39%), Birchview Capital LP (2.82%), Kennedy Capital Management LLC (0.48%) and Arcus Capital Partners LLC (0.07%). Insiders that own company stock include Highcape Capital, LP, Birchview Capital, Lp, Matthew Ferguson, Thomas Englese, David Colpman and Brigid Makes.
View institutional ownership trends
.

Shares of ELUT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Elutia investors own include NVIDIA (NVDA), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), Jabil (JBL), Meta Platforms (META) and ServiceNow (NOW).

Company Calendar

Last Earnings
8/14/2025
Today
8/27/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ELUT
CIK
1708527
Employees
180
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$8.00
Potential Upside/Downside
+233.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$53.95 million
Net Margins
-90.01%
Pretax Margin
-89.90%
Return on Equity
N/A
Return on Assets
-54.08%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.59
Quick Ratio
0.45

Sales & Book Value

Annual Sales
$24.38 million
Price / Sales
4.17
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.99) per share
Price / Book
-2.42

Miscellaneous

Outstanding Shares
42,400,000
Free Float
30,694,000
Market Cap
$101.76 million
Optionable
Not Optionable
Beta
0.88
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:ELUT) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners